ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

CpG-Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2-Mediated Remodeling of Tumor-Associated Macrophages.

Jiaqiang Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.